Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 5,334,930 | 2,227,505 | 2,227,195 | 1,771,691 | 2,417,421 |
| Cost of Goods | N/A | 399,262 | N/A | N/A | N/A |
| Gross Profit | N/A | 1,828,243 | N/A | N/A | N/A |
| Operating Expenses | N/A | 962,492 | N/A | N/A | N/A |
| Operating Income | 5,334,930 | 865,751 | 2,227,195 | -3,192,585 | 2,417,421 |
| Other Income | -5,334,930 | -21,316 | -2,227,195 | 3,192,585 | -2,417,421 |
| Pre-tax Income | N/A | 844,435 | N/A | N/A | N/A |
| Income Tax | N/A | 287,764 | N/A | N/A | N/A |
| Net Income Continuous | -2,362,681 | 568,149 | 568,162 | 487,969 | 654,540 |
| Minority Interests | N/A | -820 | N/A | N/A | N/A |
| Net Income | $-2,362,681 | $568,149 | $568,162 | $487,969 | $654,540 |
| EPS Basic Total Ops | -1.16 | 0.81 | 1.63 | 0.71 | 0.93 |
| EPS Basic Continuous Ops | -1.16 | 0.81 | 1.63 | 0.71 | 0.93 |
| EPS Diluted Total Ops | -1.16 | 0.81 | 1.63 | 0.71 | 0.93 |
| EPS Diluted Continuous Ops | -1.16 | 0.81 | 1.63 | 0.71 | 0.93 |
| EBITDA(a) | $5,334,930 | $900,184 | $2,227,195 | $-3,192,585 | $2,417,421 |